Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKesson
Julphar
US Department of Justice
Teva
Moodys
McKinsey
Mallinckrodt
Johnson and Johnson

Generated: February 21, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: icatibant acetate

« Back to Dashboard

icatibant acetate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150 NDA Shire US Manufacturing Inc. 54092-702-01 1 SYRINGE, GLASS in 1 CARTON (54092-702-01) > 3 mL in 1 SYRINGE, GLASS
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150 NDA Shire US Manufacturing Inc. 54092-702-02 1 SYRINGE, GLASS in 1 CARTON (54092-702-02) > 3 mL in 1 SYRINGE, GLASS
Shire Orphan Therap FIRAZYR icatibant acetate INJECTABLE;SUBCUTANEOUS 022150 NDA Shire US Manufacturing Inc. 54092-702-03 3 SYRINGE, GLASS in 1 CARTON (54092-702-03) > 3 mL in 1 SYRINGE, GLASS
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Deloitte
Harvard Business School
Daiichi Sankyo
Accenture
Express Scripts
Citi
Julphar
Federal Trade Commission